Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design.
Alastair Donald, Tatiana McHardy, Martin G Rowlands, Lisa-Jane K Hunter, Thomas G Davies, Valerio Berdini, Robert G Boyle, G Wynne Aherne, Michelle D Garrett, Ian Collins
Index: J. Med. Chem. 50 , 2289-92, (2007)
Full Text: HTML
Abstract
6-phenylpurines were identified as novel, ATP-competitive inhibitors of protein kinase B (PKB/Akt) from a fragment-based screen and were rapidly progressed to potent compounds using iterative protein-ligand crystallography with a PKA-PKB chimeric protein. An elaborated lead compound showed cell growth inhibition and effects on cellular signaling pathways characteristic of PKB inhibition.
Related Compounds
Related Articles:
Selectivity of kinase inhibitor fragments.
2011-07-28
[J. Med. Chem. 54 , 5131-43, (2011)]
2006-11-15
[J. Am. Chem. Soc. 128 , 14426, (2006)]
A practical synthesis of 2-((1H-pyrrolo[2,3-b]pyridine-4-yl)methylamino)-5- fluoronicotinic acid.
2006-05-12
[J. Org. Chem. 71 , 4021-4023, (2006)]
2008-04-10
[J. Med. Chem. 51 , 2147-57, (2008)]